ON24 Acquires VIBBIO
April 21, 2022
ON24 has acquired VIBBIO, a Scandinavian cloud video software company, to integrate VIBBIO’s video creation and editing capabilities into the ON24 Platform. Financial terms were not disclosed; the acquisition was funded from ON24’s cash balance and is not expected to have a material impact on its 2022 financial results.
- Buyers
- ON24
- Targets
- VIBBIO
- Industry
- Cloud & SaaS
- Location
- Oslo, Norway
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Kajabi Acquires Community Platform Vibely
November 1, 2022
Software
Kajabi, the Irvine-based all-in-one platform for knowledge creators, acquired Vibely, a community platform for creators, to integrate community-building capabilities into its product suite and rebrand Vibely as Kajabi Communities. The acquisition expands Kajabi’s creator-focused offering by enabling deeper audience engagement and monetization features within its subscription-based SaaS platform.
-
Sanofi to Acquire Vicebio for Up to $1.6 Billion
July 25, 2025
Biotechnology
Sanofi will acquire clinical-stage biopharmaceutical company Vicebio in a deal worth up to $1.6 billion, including $1.15 billion upfront and $450 million in milestone payments. Vicebio, created by Medicxi using the University of Queensland's Molecular Clamp technology, develops multivalent vaccines targeting respiratory viruses and recently advanced a bivalent RSV/hMPV candidate into Phase 1 trials.
-
Mood Media Acquires Vibenomics
March 21, 2023
Marketing & Advertising
Mood Media has acquired Vibenomics, an in-store digital advertising and audio platform provider. The acquisition expands Mood Media's in-store experiential and retail media capabilities, enabling enhanced programmatic advertising, analytics and revenue opportunities for retailers and brands.
-
Merck & Co., Inc. Acquires VelosBio Inc.
November 5, 2020
Biotechnology
Merck & Co., Inc. will acquire all outstanding shares of clinical-stage biopharmaceutical company VelosBio for $2.75 billion in cash. The acquisition adds VelosBio's lead investigational antibody-drug conjugate VLS-101 and ROR1-directed pipeline assets to Merck's oncology portfolio and is expected to close by the end of 2020, subject to customary conditions.
-
Volaris Group Acquires Symbrio AB
August 19, 2020
Cloud & SaaS
Volaris Group has completed the acquisition of Symbrio AB, a Stockholm-based provider of cloud-native procure-to-pay software for the installation industry. Volaris said the purchase will complement its portfolio by adding a market-leading SaaS procurement solution and support Symbrio’s continued autonomous operation and growth.
-
Bloom (Equity/Venture) Partners Acquires Viostream from Bailador
March 3, 2022
Cloud & SaaS
Bloom Venture/Equity Partners, a SaaS-focused investment firm, has acquired Viocorp International Pty Ltd (trading as Viostream) from Bailador Technology Investments (ASX: BTI) and other minority shareholders. The acquisition gives Bloom ownership of Viostream’s enterprise-grade cloud video management platform to accelerate product reach and international growth, with a new CEO, Evan Parker, appointed to lead the next growth phase.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.